Medical Marijuana No Further a Mystery
Outcomes were assessed from 8 several hours to 9 months subsequent randomization. Three with the five trials have been judged to have a substantial risk of bias and another two as unclear possibility. 3 experiments (nabiximols, dronabinol) showed no impact making use of validated symptom scales. Just one study that evaluated a few doses of nabiximo